News Sentiment

ALGS sentiment intelligence

Aligos Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.62 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

72/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+18.4% over one week, +25.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $50

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 72/100 classification
One-week reaction 18.4% Price confirming higher
Trend fit Trend inactive 25.4% over four weeks
Fair value -52.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 30
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
Investing.com 7
Market source 6
GlobeNewswire 4
Moomoo 3
simplywall.st 3
Investing News Network 2
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 17
Earnings 12
Deals and strategy 10
Analyst action 7
Regulatory and legal 2
Guidance 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51